Expression of cystic fibrosis lung disease modifier genes in human airway models

Gengming He1, Naim Panjwani2, Julie Avolio3

  • 1Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Program in Genetics and Genome Biology, the Hospital for Sick Children, Toronto, Ontario, Canada.

Abstract

Insights

Cultured human nasal epithelia (HNE) effectively mirrors the gene expression of cultured human bronchial epithelia (HBE) in cystic fibrosis (CF) research. This validates HNE as a viable alternative model for studying CF lung disease modifier genes and therapeutic responses.

Area of Science:

  • Pulmonary Medicine
  • Genetics
  • Cell Biology

Background:

  • Therapeutic responses to cystic fibrosis (CF) small molecule treatments vary due to CF lung disease modifier genes.
  • Cultured human bronchial epithelia (HBE) is the standard model for CF drug efficacy but is difficult to obtain.
  • Cultured human nasal epithelia (HNE) offers a more accessible alternative, but its comparability to HBE for modifier gene expression was previously unevaluated.

Purpose of the Study:

  • To assess the comparability of gene expression profiles between cultured human nasal epithelia (HNE) and cultured human bronchial epithelia (HBE).
  • To determine if HNE can serve as a reliable surrogate model for studying CF lung disease modifier genes.
  • To evaluate the equivalence of CFTR and modifier gene co-expression patterns in HNE versus HBE.

Main Methods:

  • RNA-sequencing was performed on 71 paired fresh and cultured HNE and HBE samples from 21 CF patients.
  • Genome-wide gene expression was compared between fresh and cultured cells, and between HNE and HBE using equivalence testing.
  • Co-expression relationships of CFTR and CF lung disease modifier genes were analyzed to assess functional consistency.

Main Results:

  • The culturing process minimally impacted CF lung disease modifier gene expression.
  • Over 90% of genes, including CFTR and modifier genes, exhibited equivalent expression levels between cultured HNE and HBE (fold-change < 2, FDR < 0.1).
  • No significant differences were observed in the co-expression relationships of these genes (p=0.99), indicating consistent functional interactions.

Conclusions:

  • Cultured HNE accurately reflects the gene expression profile of cultured HBE concerning CF lung disease modifier genes.
  • The findings support the use of cultured HNE as a comparable and more accessible model for CF research.
  • Biological processes involving CF lung disease modifier genes are likely consistent between HNE and HBE models.